The integration of psychedelic therapies into the healthcare industry represents a significant stride towards advancing mental health treatments. But, what will the future of psychedelic therapies actually look like? How may they be rolled out and, how will this impact the future of mental health treatments on the broader level?

Join Psychiatrist and Clinician-Scientist, Dr. Adam Bayes, CEO/Co-Founder of Psylo, Josh Ismin and Co-Founder of Enosis Therapeutics Agnieszka Sekula as they share their expertise about psychedelics and the future of mental health treatments.